Atara Biotherapeutics Email Formats
Biotechnology Research • 
Thousand Oaks, California, United States • 101-200 Employees
Atara Biotherapeutics Email Formats
Atara Biotherapeutics uses 5 email formats. The most common is {first name}{last name} (e.g., johndoe@atarabio.com), used 61.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@atarabio.com | 61.3% |
{first initial}{last name} | jdoe@atarabio.com | 34.7% |
{second initial}{last name} | odoe@atarabio.com | 1.3% |
{last name} | doe@atarabio.com | 1.3% |
{last name}{last name} | doedoe@atarabio.com | 1.3% |
Key Contacts at Atara Biotherapeutics
Jonathan Lucas
Sr. Director, Information Technology
Guido Palermo
Sr. Director, External Manufacturing
Jake Buchholtz
Senior Director, Global Operations
Reddy Guda
Director Of Information Technology
Judy Mchugh
Sr. Director, Operations And Business Systems
Xianhui Chen
Associate Director
Ryan Flynn
Associate Director, Manufacturing Services
Anna Fair
Director, People Business Partner
Michael Choy
Associate Director Quality Assurance
Christina Pham
Director, Preclinical Science
Company overview
| Headquarters | 2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA 91320, US |
| Phone number | +16502788930 |
| Website | |
| NAICS | 541714 |
| SIC | 738 |
| Keywords | Biotechnology, Oncology, MS, Multiple Sclerosis, Immuno-Oncology, Immunotherapy, Cancer, Cell Therapy, Immunology, Regenerative Medicine, Hematology, Lymphoma, Gene Therapy, Autoimmune Diseases, Bone Marrow Transplant, T-Cells, Solid Tumors, Stem Cell Transplant, CMV, Off The Shelf, Atra, Car T, Allogeneic Cd19 Car T, Allogeneic Ebv Car T-Cell Platform, Atara, Atara Bio, Ctls, Cytomegalovirus, EBV, Ebv Lymphoma, Epstein-Barr Virus, Ptld, Allogeneic, Cytotoxic T Lymphocytes, Lymphoproliferative Disorders, Nasopharyngeal Carcinoma, Oncoviruses, Post-Transplant Lymphoproliferative Disorder, Secondary Lymphoma, Secondary Malignancy, Solid Organ Transplant, Allogeneic Car T-Cell Therapies, Progressive Multiple Sclerosis |
| Founded | 2012 |
| Employees | 101-200 |
| Socials |
About Atara Biotherapeutics
Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. With our lead program receiving marketing authorization in Europe, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Atara Biotherapeutics has 74 employees across 12 departments.
Departments
Number of employees
Funding Data
Explore Atara Biotherapeutics's funding history, including investment rounds, total capital raised, and key backers.
Atara Biotherapeutics Tech Stack
Discover the technologies and tools that power Atara Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Digital asset management
Security
Video players
Miscellaneous
JavaScript libraries
UI frameworks
JavaScript libraries
CDN
WordPress themes
JavaScript libraries
Webmail
India
Portugal
Canada
PakistanFrequently asked questions
4.8
40,000 users
